Target intelligence / Profile preview

Chromosome segregation 1-like protein (CSE1L) (CSE1L)

Target
CSE1L
Molecular classification
Exportin, Nuclear transport factor, Importin-beta family
01

Overview

Chromosome segregation 1-like protein (CSE1L), also known as Cellular Apoptosis Susceptibility (CAS) protein, is a member of the importin-beta family of nuclear transport receptors (UniProt P55060; NCBI Gene 1434). It functions primarily as an exportin, specifically mediating the nuclear export of importin-alpha, which is essential for the continuous cycle of nuclear protein import (Tai et al., 2010). Beyond its transport function, CSE1L plays a significant role in regulating the cell cycle, apoptosis, and the shedding of microvesicles that facilitate tumor metastasis (Jiang, 2016). CSE1L is frequently overexpressed in a wide range of human malignancies, including melanoma, breast, and colon cancers, where it is associated with increased cell proliferation and poor clinical outcomes (Poutani et al., 2021). As a therapeutic target, CSE1L is being explored through the use of RNA interference (siRNA) and antisense oligonucleotides to downregulate its expression, as well as experimental small molecules like Gambogic acid designed to disrupt its function (Tai et al., 2010). Inhibiting CSE1L leads to the accumulation of importin-alpha in the nucleus, disrupting cellular homeostasis and inducing programmed cell death in cancer cells.

Other names
CASCellular apoptosis susceptibility proteinExportin-2XPO2CSE1
02

Mechanism of action

Downregulation of CSE1L expression via RNA interference or antisense technology, or inhibition of its nuclear export function, leading to the disruption of importin-alpha recycling and induction of apoptosis (Tai et al., 2010; Jiang, 2016).

03

Biological functions

Nuclear-cytoplasmic transportCell cycle regulationApoptosisCell proliferationMicrovesicle sheddingMitotic spindle assembly
04

Disease associations

CancerMetastasisMelanomaBreast cancerColorectal cancerHepatocellular carcinoma
05

Safety considerations

Potential for systemic toxicity due to its role in normal cell division (Tai et al., 2010)Risk of off-target effects with RNA-based therapeuticsEssentiality for nuclear transport in all eukaryotic cells (UniProt P55060)
06

Interacting drugs

siRNA-CSE1L (Experimental)

3 more in the full profile.

07

Biomarkers

CSE1L mRNA expression levels (Jiang, 2016)CSE1L protein expression (IHC) (Poutani et al., 2021)Serum CSE1L levels (Tai et al., 2010)Importin-alpha localization (UniProt P55060)

Beyond the preview

Go deeper on Chromosome segregation 1-like protein (CSE1L) (CSE1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome segregation 1-like protein (CSE1L) (CSE1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call